A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
Healthy volunteers are being recruited for this pharmacokinetics study. The objective is to
characterize the pharmacokinetic properties of maraviroc alone and when administered with
rifabutin and to assess rifabutin and 25-O-desacetyl-rifabutin pharmacokinetics compared to
the literature.